The leading manufacturer and exporter of Active Pharmaceutical Integredients(API), Ind-Swift is planning to merge with Essix biosciences and Dashmesh Medicare.

See robust revenue from US, Europe ahead: Ind Swift

In an interview with CNBC-TV18, Nav Rattan Munjal, VC & MD, IndSwift Laboratories spoke on the company's business plans.

Ind-Swift Labs eyes good volumes on exports to Japan

Ind-Swift Labs has got a phamaceutical and medical devices agency approval from the Japanese government for two drugs. In an interview with CNBC-TV18, Gopal Munjal, Chairman, Ind-Swift Labs spoke on the approval and the investment the facility would require.